High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma

Virchows Archiv

Volumn 464, Issue 4, 2014, Pages 443-452

  Ma, Yingchun ^a,b   Ren, Yubo ^b   Zhang, Xian ^b   Lin, Li ^b   Liu, Yihua ^b   Rong, Fengnian ^a   Wen, Wenjuan ^b   Li, Fengli ^b  

^a SHANDONG UNIVERSITY   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Chemotherapy response; Golgi phosphoprotein 3 (GOLPH3); Oncogene; Ovarian cancer; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; GOLGI PHOSPHOPROTEIN 3; MESSENGER RNA; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CELL GRANULE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYSTADENOMA; CYTOPLASM; DISEASE ASSOCIATION; EPITHELIAL OVARIAN CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CARCINOMA; OVARY TUMOR; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR BIOPSY; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; CHINA; DISEASE PROGRESSION; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899107183     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-014-1536-3     Document Type: Article

References (31)

1. Runnebaum IB, Stickeler E (2001) Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 127(2):73-79
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA: Cancer J Clin 57(1):43-66
3. Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-Saaib R, Yu H, Azori M, Rutherford T, Schwartz PE, Mor G (2008) Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res: Off J Am Assoc Cancer Res 14(4):1065-1072. doi: 10.1158/1078-0432.CCR-07-1569
4. Rustin GJ, Nelstrop AE, McClean P, Brady MF, McGuire WP, Hoskins WJ, Mitchell H, Lambert HE (1996) Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol: Off J Am Soc Clin Oncol 14(5):1545-1551
5. Ozols RF (2002) Update on the management of ovarian cancer. Cancer J 8(Suppl 1):S22-S30
6. Bell AW, Ward MA, Blackstock WP, Freeman HN, Choudhary JS, Lewis AP, Chotai D, Fazel A, Gushue JN, Paiement J, Palcy S, Chevet E, Lafreniere-Roula M, Solari R, Thomas DY, Rowley A, Bergeron JJ (2001) Proteomics characterization of abundant Golgi membrane proteins. J Biol Chem 276(7):5152-5165. doi: 10.1074/jbc.M006143200
7. Nakashima-Kamimura N, Asoh S, Ishibashi Y, Mukai Y, Shidara Y, Oda H, Munakata K, Goto Y, Ohta S (2005) MIDAS/GPP34, a nuclear gene product, regulates total mitochondrial mass in response to mitochondrial dysfunction. J Cell Sci 118(Pt 22):5357-5367. doi: 10.1242/jcs.02645
8. Wu CC, Taylor RS, Lane DR, Ladinsky MS, Weisz JA, Howell KE (2000) GMx33: a novel family of trans-Golgi proteins identified by proteomics. Traffic 1(12):963-975
9. Snyder CM, Mardones GA, Ladinsky MS, Howell KE (2006) GMx33 associates with the trans-Golgi matrix in a dynamic manner and sorts within tubules exiting the Golgi. Mol Biol Cell 17(1):511-524. doi: 10.1091/mbc.E05-07-0682
10. Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, Huang J, Saci A, Widlund HR, Fisher DE, Xiao Y, Rimm DL, Protopopov A, Wong KK, Chin L (2009) GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 459(7250):1085-1090. doi: 10.1038/nature08109
11. Scott KL, Chin L (2010) Signaling from the Golgi: mechanisms and models for Golgi phosphoprotein 3-mediated oncogenesis. Clin Cancer Res: An Off J Am Assoc Cancer Res 16(8):2229-2234. doi: 10.1158/1078-0432.CCR-09-1695
12. Tavassoli FA, Devilee P (2003) Pathology and genetics of tumours of the breast and female genital organs, vol 4. World Health Organization
13. Oncology FCoG (2009) Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet: Off Organ Int Fed Gynaecol Obstet 105(1):3-4
14. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205-216
15. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124(3):471-484. doi: 10.1016/j.cell.2006.01.016
16. Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149(6):1192-1205. doi: 10.1016/j.cell.2012.05.012
17. Sabatini DM (2006) mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6(9):729-734. doi: 10.1038/nrc1974
18. Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126(5):855-867
19. Li XY, Liu W, Chen SF, Zhang LQ, Li XG, Wang LX (2011) Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study. J Neuro-Oncol 105(2):159-163. doi: 10.1007/s11060-011-0573-x
20. Kunigou O, Nagao H, Kawabata N, Ishidou Y, Nagano S, Maeda S, Komiya S, Setoguchi T (2011) Role of GOLPH3 and GOLPH3L in the proliferation of human rhabdomyosarcoma. Oncol Reports 26(5):1337-1342. doi: 10.3892/or.2011.1413
21. Wang JH, Chen XT, Wen ZS, Zheng M, Deng JM, Wang MZ, Lin HX, Chen K, Li J, Yun JP, Luo RZ, Song LB (2012) High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis. PloS One 7(10):e45622. doi: 10.1371/journal.pone.0045622
22. Li H, Guo L, Chen SW, Zhao XH, Zhuang SM, Wang LP, Song LB, Song M (2012) GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J Transl Med 10:168. doi: 10.1186/1479-5876-10-168
23. Zeng Z, Lin H, Zhao X, Liu G, Wang X, Xu R, Chen K, Li J, Song L (2012) Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin Cancer Res: An Off J Am Assoc Cancer Res 18(15):4059-4069. doi: 10.1158/1078-0432.CCR-11-3156
24. Hua X, Yu L, Pan W, Huang X, Liao Z, Xian Q, Fang L, Shen H (2012) Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol 7:127. doi: 10.1186/1746-1596-7-127
25. Ali MF, Chachadi VB, Petrosyan A, Cheng PW (2012) Golgi phosphoprotein 3 determines cell binding properties under dynamic flow by controlling Golgi localization of core 2 N-acetylglucosaminyltransferase 1. J Biol Chem 287(47):39564-39577. doi: 10.1074/jbc.M112.346528
26. St Hill CA, Baharo-Hassan D, Farooqui M (2011) C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells. PloS One 6(1):e16281. doi: 10.1371/journal.pone.0016281
27. Carlow DA, Gossens K, Naus S, Veerman KM, Seo W, Ziltener HJ (2009) PSGL-1 function in immunity and steady state homeostasis. Immunol Rev 230(1):75-96. doi: 10.1111/j.1600-065X.2009.00797.x
28. Beum PV, Singh J, Burdick M, Hollingsworth MA, Cheng PW (1999) Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. J Biol Chem 274(35):24641-24648
29. Kupryjanczyk J, Szymanska T, Madry R, Timorek A, Stelmachow J, Karpinska G, Rembiszewska A, Ziolkowska I, Kraszewska E, Debniak J, Emerich J, Ulanska M, Pluzanska A, Jedryka M, Goluda M, Chudecka-Glaz A, Rzepka-Gorska I, Klimek M, Urbanski K, Breborowicz J, Zielinski J, Markowska J (2003) Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen. Br J Cancer 88(6):848-854. doi: 10.1038/sj.bjc.6600789
30. de Graeff P, Crijns AP, Ten Hoor KA, Klip HG, Hollema H, Oien K, Bartlett JM, Wisman GB, de Bock GH, de Vries EG, de Jong S, van der Zee AG (2008) The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. Br J Cancer 99(2):341-349. doi: 10.1038/sj.bjc.6604471
31. Zhou J, Xu T, Qin R, Yan Y, Chen C, Chen Y, Yu H, Xia C, Lu Y, Ding X, Wang Y, Cai X, Chen J (2012) Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis. J Neuro-Oncol 110(2):195-203. doi: 10.1007/s11060-012-0970-9